- Home
- AVTX vs MODD Comparison
AVTX vs MODD Comparison
Compare AVTX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- MODD
- Stock Information
- Founded
- AVTX 2011
- MODD 1998
- Country
- AVTX United States
- MODD United States
- Employees
- AVTX N/A
- MODD N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- AVTX Health Care
- MODD Health Care
- Exchange
- AVTX Nasdaq
- MODD Nasdaq
- Market Cap
- AVTX 57.4M
- MODD 55.3M
- IPO Year
- AVTX 2015
- MODD N/A
- Fundamental
- Price
- AVTX $4.25
- MODD $1.00
- Analyst Decision
- AVTX Strong Buy
- MODD
- Analyst Count
- AVTX 6
- MODD 0
- Target Price
- AVTX $34.20
- MODD N/A
- AVG Volume (30 Days)
- AVTX 66.4K
- MODD 95.0K
- Earning Date
- AVTX 05-20-2025
- MODD 06-20-2025
- Dividend Yield
- AVTX N/A
- MODD N/A
- EPS Growth
- AVTX N/A
- MODD N/A
- EPS
- AVTX N/A
- MODD N/A
- Revenue
- AVTX $441,000.00
- MODD N/A
- Revenue This Year
- AVTX N/A
- MODD N/A
- Revenue Next Year
- AVTX N/A
- MODD N/A
- P/E Ratio
- AVTX N/A
- MODD N/A
- Revenue Growth
- AVTX N/A
- MODD N/A
- 52 Week Low
- AVTX $4.15
- MODD $0.68
- 52 Week High
- AVTX $16.00
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- AVTX 31.02
- MODD 52.36
- Support Level
- AVTX $4.80
- MODD $0.97
- Resistance Level
- AVTX $5.26
- MODD $1.15
- Average True Range (ATR)
- AVTX 0.45
- MODD 0.09
- MACD
- AVTX 0.03
- MODD 0.01
- Stochastic Oscillator
- AVTX 11.96
- MODD 50.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.